Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-28Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, pharmacodynamics, and immunogenicity of JNJ-63723283 as monotherapy or with Erdafitinib i…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: CLN-418 Study on Subjects With Advanced Solid Tumors [Phase 1]
The Phase 1 study of CLN-418 in subjects with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 safety study of GL-ONC1 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 [Phase 1]
This Phase 1 study evaluated safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of NC762 in patients with advanced or metastatic solid tumors has been terminated, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-90011 in participants with relapsed/refractory solid tumors and Non-Hodgkin lymphoma. Th…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Phase I Study of HS-20108 in Participants With Advanced Solid Tumors [Phase 1]
This document provides an update on a Phase I study of the investigational agent HS-20108 in participants with advanced solid tumors, which …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 [Phase 1]
Phase 1 clinical trial evaluating the EpCAM-targeting imaging agent [99mTc]Tc(CO)3-(HE)3-Ec1 in adults with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors [Phase 1]
Phase 1 safety and tolerability study of T-1101 tosylate capsules for advanced solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) [Phase 1, Phase 2]
Phase 1/2 study MK-1308-001 evaluating Quavonlimab in combination with Pembrolizumab in advanced solid tumors has completed. Results were po…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Safety and Tolerability of Intravenous Administration of ICVB-1042 [Phase 1]
Phase 1 safety and tolerability assessment of intravenous ICVB-1042 in patients with solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors [Phase 1]
Phase 1 trial assessing the effect of Tusamitamab Ravtansine on QTc interval in participants with metastatic solid tumors; the study has bee…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors [Phase 1]
Phase 1 trial of KT-333 in adults with refractory lymphomas and solid tumors reports safety, pharmacokinetics, pharmacodynamics, and prelimi…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of BMS-986442 with nivolumab, with or without chemotherapy, in solid tumors and non-small cell lung cancer has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating EVM16 injection alone and in combination with tislelizumab in advanced or recurrent solid tumors; study is…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors [Phase 1]
Phase 1 clinical trial update of LP-284 in adults with relapsed or refractory lymphomas and advanced solid tumors, focusing on safety, pharm…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors [Phase 1, Phase 2]
Valerio Therapeutics terminated a Phase 1/2 trial of VIO-01 in patients with advanced or metastatic solid tumors, including breast, ovarian,…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of AK112 for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial status update indicating that AK112's Phase 1/2 study in advanced solid tumors has been completed. The trial was sponsored by…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors [Phase 1]
This report provides an update on a Phase 1 safety study of sterile compound C31510 for injection in subjects with solid tumors. The trial h…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors [Phase 1]
A Phase 1 trial of BP31510 Ubidecarenone nanosuspension for intravenous injection in solid tumors has completed, according to the update. Th…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer [Phase 1]
The document reports completion of a Phase 1 trial evaluating selumetinib in combination with cyclosporine for advanced solid tumors or adva…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Evaluation of SAR408701 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated SAR408701 in patients with advanced solid tumors. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of AB154 in adults with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors [Phase 1]
Phase 1 first-in-human trial update reports on the safety and tolerability of MP0317 in patients with relapsed/refractory advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies [Phase 1]
Phase 1 study evaluating the safety and tolerability of RXC004 in patients with advanced malignancies; results have been posted.